C21 Investments (CXXIF) Cash & Equivalents (2017 - 2026)

C21 Investments (CXXIF) has reported Cash & Equivalents for 10 consecutive years, with $2.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash & Equivalents fell 1.2% year-over-year to $2.6 million in Q2 2026; TTM through Jun 2026 was $2.6 million, a 1.2% decrease from a year earlier, with the FY2026 full-year figure at $2.2 million, down 14.9% from the prior year.
• Cash & Equivalents was $2.6 million for Q2 2026 at C21 Investments, up from $2.2 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $6.2 million in Q1 2022 and troughed at $1.8 million in Q2 2023.
• A 5-year average of $2.7 million and a median of $2.5 million in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents plunged 69.63% in 2023 and surged 35.21% in 2025, its largest moves.
• Over 5 years, Cash & Equivalents stood at $3.3 million in 2022, then tumbled by 41.9% to $1.9 million in 2023, then jumped by 31.05% to $2.5 million in 2024, then slipped by 3.13% to $2.4 million in 2025, then climbed by 8.47% to $2.6 million in 2026.
• The last three Cash & Equivalents figures came in at $2.6 million (Q2 2026), $2.2 million (Q1 2026), and $2.4 million (Q4 2025), per Business Quant data.